Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 0615-8006

6 FDA label images from Ncs Healthcare Of Ky, Llc Dba Vangard Labs · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 0615-8006). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Atorvastatin Calcium Tabs 8006 1)

Chemical-structure (Atorvastatin Calcium Tabs 8006 1)
Chemical structure of atorvastatin calcium, depicted with calcium ions and atorvastatin molecules shown in a structural formula format.*
FDA Label Image

Figure-01 (Atorvastatin Calcium Tabs 8006 2)

Figure-01 (Atorvastatin Calcium Tabs 8006 2)
A line graph showing cumulative incidence percentage over time in years with two plotted lines comparing Atorvastatin and placebo groups. The graph includes a hazard ratio (HR=0.64) with confidence intervals and a p-value indicating statistical significance.*
FDA Label Image

Figure-02 (Atorvastatin Calcium Tabs 8006 3)

Figure-02 (Atorvastatin Calcium Tabs 8006 3)
A line graph showing cumulative hazard percentage over time (years) comparing Atorvastatin and placebo groups. The x-axis indicates time to first primary endpoint over four years, and the y-axis shows cumulative hazard percentage. The Atorvastatin group has a consistently lower cumulative hazard than the placebo group. A hazard ratio (HR) of 0.63 with confidence intervals and a p-value is noted on the graph.*
FDA Label Image

Figure-03 (Atorvastatin Calcium Tabs 8006 4)

Figure-03 (Atorvastatin Calcium Tabs 8006 4)
A line graph comparing the percentage of subjects experiencing a major cardiovascular event over a period of up to 5 years for Atorvastatin 10 mg and 80 mg doses. The x-axis represents time to first major cardiovascular endpoint in years, and the y-axis shows the percentage of subjects experiencing the event. The graph includes a hazard ratio (HR) of 0.78 with a confidence interval (0.69-0.89) and a p-value of 0.0002, indicating statistical analysis of outcomes between the two doses.*
FDA Label Image

Principal Display Panel (Atorvastatin Calcium Tabs 8006 5)

Principal Display Panel (Atorvastatin Calcium Tabs 8006 5)
Label image for Atorvastatin Calcium tablets USP 10 mg by NCS HealthCare of KY, LLC dba Vangard Labs, featuring barcode, lot, and expiration information. The label states film-coated oral tablets with a quantity of 30, with packaging by Apotex and Vangard, Glasgow, KY. Storage instructions and a dosage note are included, with multiple individual barcoded labels for institutional use.*
FDA Label Image

Principal Display Panel (Atorvastatin Calcium Tabs 8006 6)

Principal Display Panel (Atorvastatin Calcium Tabs 8006 6)
The image shows multiple identical label panels for Atorvastatin Calcium tablets USP 10 mg, film coated, packaged by Vangard Labs in Glasgow, KY. Each panel includes the product name, strength, lot number, and a barcode. The bottom part displays detailed labeling showing a vial with 30 tablets, storage instructions, and mentions repackaging by Vangard Labs and manufacturing by Apotex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.